Overactive Bladder - Results from #90

Assessing the Use of BotulinumtoxinA for Hyperactive Urinary Tract Dysfunction a Decade after Approval: A Single-Blind Study to Evaluate the Reduction in Pain in OnabotulinumtoxinA Detrusor Injection Using Different Injection Needles. October 20, 2024

The Management of Children and Adolescents with Overactive Bladder Refractory to Treatment with Parasacral Transcutaneous Electrical Nerve Stimulation. October 18, 2024

Sexual Dysfunction in Patients with Overactive Bladder Syndrome Treated with Botulinum Toxin. October 18, 2024

Discrete Mathematics in Dynamic Network Analysis: Long-Term Efficacy Evaluation of Fotona Laser Therapy for Overactive Bladder Syndrome Using Clustering-Based Patient Subgroup Identification. October 13, 2024

Effectiveness of Electrical Stimulation Combined with Pelvic Floor Muscle Training on Female Sexual Dysfunction with Overactive Bladder: A Randomized Controlled Clinical Trial. October 13, 2024

Protocol for a Series of Systematic Reviews and Network Meta-analyses of Randomized Controlled Trials of Medications for Patients with Overactive Bladder Symptoms. October 13, 2024

Association of healthy eating index-2015 and overactive bladder: a cross-sectional study. October 6, 2024

Efficacy of botulinum toxin in the management of refractory de novo overactive bladder symptoms in women after midurethral sling placement: retrospective, single center study. October 6, 2024

Safety and effectiveness of mirabegron for children and adolescents with refractory idiopathic overactive bladder for improving urinary symptoms: a systematic review. October 6, 2024

Associations of overactive bladder (OAB) with suicidal ideation incidence and all-cause mortality among the U.S. population. October 6, 2024

Differences in Advanced Therapeutic Modalities for Overactive Bladder in the United States by Race. October 6, 2024

Mirabegron Versus Placebo and Other Therapeutic Modalities in the Treatment of Patients with Overactive Bladder Syndrome-A Systematic Review. October 6, 2024

SYNCHRONIZE: Real-World Retrospective Safety Analysis of Patients Treated with OnabotulinumtoxinA for More than One Therapeutic Indication September 30, 2024

Trends of Overactive Bladder and Pharmacologic Treatment Among U.S. Women. September 29, 2024

Steps toward identification of a novel cue-positive overactive bladder phenotype in women with high-bother urinary urgency. September 29, 2024

Association of Aggression with Lower Urinary Tract Symptoms and Overactive Bladder in Men: Observations from a Large Population-representative Study. September 29, 2024

Botulinum Neurotoxin Type A in paediatric non-neurogenic therapy resistant overactive bladder: a cohort study. September 29, 2024

A Multicenter Prospective Sham-Controlled Trial Evaluating a Physiologic Closed-Loop Wearable Tibial Neuromodulation System for Overactive Bladder (REDUCEOAB). September 22, 2024

Association Between Proton Pump Inhibitor Use and Overactive Bladder Risk in Adults: A Cross-Sectional Study. September 22, 2024

Association analysis of ADRB3:rs4994 with urodynamic outcome, six months after a single intra-detrusor injection of botulinum toxin, in women with overactive bladder. September 22, 2024

Page 5 of 125